Scrip Asks…What Does 2025 Hold for Biopharma?
Jan 2025
James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2025 as part of Citeline’s Scrip Asks series.
Summary
-
Lincoln International’s James West offers Scrip a perspective on the 2025 biopharma market.
- Sign up to receive Lincoln's perspectives
Share: 
Contributor
Meet Professionals with Complementary Expertise in Mergers & Acquisitions
I am a rigorous advocate for my clients with a hands-on, communicative approach, focused on delivering intense advocacy and outlier results.
Sean Bennis
Managing Director & Co-head of Industrials
Chicago
I am enthusiastic about creating sustainable growth and the highest value for our clients and strive to leave a positive footprint beyond any successful M&A transaction.
Friedrich Bieselt
Managing Director & Head of Business Services, Europe
Frankfurt
I enjoy leading clients and realizing their objectives, while structuring solutions to issues that are both intriguing and challenging.
Øyvind Bjordal
Managing Director | Head of Switzerland
Zurich
I am inspired by working with entrepreneurs and innovators who feel passionately about what they are creating.
William Bowmer
Managing Director & Co-head of Technology, U.S.
San Francisco
I deliver a hands-on approach to provide strategic advice to my clients throughout the transaction and beyond.
Chris Brooks
Managing Director & Co-head of Technology, Europe
London
